NCT07578233Completed
Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Muscle Invasive Bladder Cancer
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
This research aimed to determine how accurately multiparametric magnetic resonance imaging (MRI), when interpreted using the VI-RADS scoring system, can distinguish between invasive and non-invasive bladder cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 5 May 2026
- Start date
- 1 Aug 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- Ain Shams University
- Diseases
- Bladder cancer
- NCT number
- NCT07578233
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 1 Aug 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications to Transurethral Resection (like unfitness for anesthesia or urethral strictures).
Lab values
- Elevated serum creatinine levels (precluding IV contrast-enhanced imaging).
Other
- Contraindications to MRI (such as metallic prostheses or pacemakers).
Who the study is looking for
- Both sexes.
- Patients with bladder masses diagnosed through ultrasound, computed tomography, or magnetic resonance imaging (MRI), who were scheduled for cystoscopy.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.